The global Pruritus Therapeutics Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Disease (Atopic dermatitis, Allergic contact dermatitis, Urticaria, Others), By Product (Corticosteroids, Antihistamines, Local anesthetics, Counterirritants, Immunosuppressant, Calcineurin inhibitors, Others).
Addressing itch-related disorders and dermatological conditions, the Pruritus Therapeutics Market offers pharmaceutical treatments and topical remedies for managing pruritus (itching) associated with skin diseases, allergic reactions, and systemic disorders. Pruritus therapeutics may include antihistamines, corticosteroids, calcineurin inhibitors, and topical emollients, as well as novel therapies targeting itch-specific pathways and neurogenic mechanisms. This market encompasses prescription drugs, over-the-counter (OTC) remedies, and medical devices for itch relief and skin hydration provided by pharmaceutical companies, dermatology clinics, and retail pharmacies. The growth of this market is driven by factors such as the increasing prevalence of skin disorders, the growing demand for effective pruritus management, and advancements in pruritus research leading to the development of targeted therapies and personalized treatment approaches.
A significant trend in the Pruritus Therapeutics market is the continuous advancements in targeted therapies for the treatment of pruritus, or itching, across various dermatologic and systemic conditions. As our understanding of the underlying mechanisms of pruritus improves, there is a shift towards the development of novel therapeutics that target specific pathways involved in itch sensation, including neurogenic, inflammatory, and immune-mediated pathways. These targeted therapies offer the potential for more effective and selective relief of pruritus symptoms while minimizing side effects, driving innovation and growth in the pruritus therapeutics market.
A key driver in the Pruritus Therapeutics market is the increasing prevalence of chronic skin conditions associated with pruritus, such as atopic dermatitis, psoriasis, and chronic urticaria. Pruritus is a common symptom across various dermatologic disorders, affecting millions of individuals worldwide and significantly impacting quality of life. The growing incidence and prevalence of chronic skin conditions drive the demand for effective pruritus therapeutics that provide rapid and long-lasting relief from itching, addressing the unmet medical needs of patients and healthcare providers.
An enticing opportunity in the Pruritus Therapeutics market lies in the development of non-opioid therapies for the management of pruritus, particularly in chronic and systemic conditions. With the opioid epidemic and concerns about opioid-related adverse effects, there is a growing need for alternative pharmacologic approaches to pruritus management that do not rely on opioid medications. Non-opioid pruritus therapies, such as topical agents, immunomodulators, antihistamines, and novel biologic agents, offer promising alternatives for relieving pruritus symptoms while minimizing the risk of addiction, tolerance, and respiratory depression associated with opioid use. By investing in research and development of non-opioid pruritus therapeutics, pharmaceutical companies can address this emerging market need, differentiate their product offerings, and capitalize on the growing demand for safer and more effective treatments for pruritus across diverse patient populations, thus unlocking new opportunities for growth and innovation in the pruritus therapeutics market.
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbvie Inc
Actavis Plc
Amgen Inc
Astellas Pharma
Bristol-Myers Squibb
Cara Therapeutics
GlaxoSmithKline Plc
Myaln NV
Novartis AG
Pfizer Inc
Sanofi
Teva Pharmaceuticals
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Pruritus Therapeutics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Pruritus Therapeutics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Pruritus Therapeutics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Pruritus Therapeutics Market Size Outlook, $ Million, 2021 to 2030
3.2 Pruritus Therapeutics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Pruritus Therapeutics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Pruritus Therapeutics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Pruritus Therapeutics Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Pruritus Therapeutics Industry
4.2 Key Market Trends in Pruritus Therapeutics Industry
4.3 Potential Opportunities in Pruritus Therapeutics Industry
4.4 Key Challenges in Pruritus Therapeutics Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Pruritus Therapeutics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Pruritus Therapeutics Market Outlook by Segments
7.1 Pruritus Therapeutics Market Outlook by Segments, $ Million, 2021- 2030
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
8 North America Pruritus Therapeutics Market Analysis and Outlook To 2030
8.1 Introduction to North America Pruritus Therapeutics Markets in 2024
8.2 North America Pruritus Therapeutics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Pruritus Therapeutics Market size Outlook by Segments, 2021-2030
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
9 Europe Pruritus Therapeutics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Pruritus Therapeutics Markets in 2024
9.2 Europe Pruritus Therapeutics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Pruritus Therapeutics Market Size Outlook by Segments, 2021-2030
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
10 Asia Pacific Pruritus Therapeutics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Pruritus Therapeutics Markets in 2024
10.2 Asia Pacific Pruritus Therapeutics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Pruritus Therapeutics Market size Outlook by Segments, 2021-2030
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
11 South America Pruritus Therapeutics Market Analysis and Outlook To 2030
11.1 Introduction to South America Pruritus Therapeutics Markets in 2024
11.2 South America Pruritus Therapeutics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Pruritus Therapeutics Market size Outlook by Segments, 2021-2030
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
12 Middle East and Africa Pruritus Therapeutics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Pruritus Therapeutics Markets in 2024
12.2 Middle East and Africa Pruritus Therapeutics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Pruritus Therapeutics Market size Outlook by Segments, 2021-2030
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbvie Inc
Actavis Plc
Amgen Inc
Astellas Pharma
Bristol-Myers Squibb
Cara Therapeutics
GlaxoSmithKline Plc
Myaln NV
Novartis AG
Pfizer Inc
Sanofi
Teva Pharmaceuticals
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Disease
Atopic dermatitis
Allergic contact dermatitis
Urticaria
Others
By Product
Corticosteroids
Antihistamines
Local anesthetics
Counterirritants
Immunosuppressant
Calcineurin inhibitors
Others
The global Pruritus Therapeutics Market is one of the lucrative growth markets, poised to register a 4.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbvie Inc, Actavis Plc, Amgen Inc, Astellas Pharma, Bristol-Myers Squibb, Cara Therapeutics, GlaxoSmithKline Plc, Myaln NV, Novartis AG, Pfizer Inc, Sanofi, Teva Pharmaceuticals
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume